1.Study on the technology to produce inactivated rabies vaccine on the primary hamster kidney cell at laboratory scale
Journal of Preventive Medicine 2005;15(5):123-127
Vnukovo-32 a cell culture rabies is used to study the vaccine strain technology of inactivated culture rabies vaccine production in primary hamster kidney cells. The master and working seeds meet the criteria of rabies vaccine strain titer (5.5 log LD 50 - 7.1 log LD 50/ml) according to WHO standard. During the study, we have used the procedure for inactivated, non concentrated rabies vaccine production of Russia and other countries procedures as references. The result was we constructed the procedure for inactivated, concentrated cell culture rabies vaccine production at laboratory scale.
Rabies Vaccines
;
Cells, Laboratories
2.Cell Processing: Current Status and Future Directions.
David STRONCEK ; Elizabeth J READ
Yonsei Medical Journal 2004;45(Suppl):S1-S4
Specialized clinical cell processing began in the Department of Transfusion Medicine at the National Institutes of Health in 1984. The number and complexity of procedures performed increased quickly and in 1997 a highly specialized cell processing laboratory was opened. The laboratory has approximately 3,000 square feet, specialized air handing, a highly trained staff, and written laboratory procedures. In addition to standard laboratory equipment, the laboratory has numerous cell isolation instruments, flow cytometers, and automated cell counting instruments. The laboratory supports blood and bone marrow transplant protocols by isolating CD34+ stem cells, removing T lymphocytes, culturing lymphocytes to eliminate donor lymphocytes that are reactive with recipient alloantigens, and stimulating lymphocytes to induce Th2 type cells to reduce graft versus host disease. The laboratory has also been preparing dendritic cells to support protocols using immune therapy to treat cancer. In addition, pancreatic islet cells are isolated from organ donors for transplantation to treat type I diabetes mellitus.
Antigens, CD34/metabolism
;
Cell Separation
;
Cell Transplantation/*trends
;
Hematopoietic Stem Cells/metabolism
;
Humans
;
Immunotherapy
;
Islets of Langerhans Transplantation
;
Laboratories/*trends
;
Lymphocyte Transfusion
;
National Institutes of Health (U.S.)/*trends
;
Neoplasms/therapy
;
United States